XML 28 R18.htm IDEA: XBRL DOCUMENT v3.26.1
EQUITY COMPENSATION PLANS
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
EQUITY COMPENSATION PLANS

8. EQUITY COMPENSATION PLANS

 

Stock Incentive Plans

 

Our board of directors adopted and our stockholders approved our 2024 Plan, which became effective on August 12, 2024. The purpose of the 2024 Plan is to enhance the Company’s ability to attract, retain and motivate individuals by providing these individuals with equity ownership and incentive opportunities. All of the Company’s employees, as well as all of the Company’s non-employee directors and other consultants, advisors and other persons who provide services to the Company are eligible to receive incentive awards under the 2024 Plan, including stock options grants, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock units (“RSUs”), and other awards. Up to 3,316,444 shares of common stock were originally reserved for future issuance under the 2024 Plan, which number included 496,801 shares of common stock reserved for issuance under the 2015 Plan as of the closing date of the IPO. In addition, the number of shares of common stock available for issuance under the 2024 Plan is subject to an annual increase on the first day of each calendar year beginning on January 1, 2025 and ending on and including January 1, 2034 equal to the lesser of (i) 5% of the aggregate number of shares of common stock outstanding on the final day of the immediately preceding calendar year and (ii) such smaller number of shares of common stock as determined by the Board. Effective January 1, 2026, the number of shares of common stock reserved for issuance under the 2024 Plan increased by 1,162,260 pursuant to the aforementioned evergreen provision. As of March 31, 2026, there were 3,346,601 shares available for grant under the 2024 Plan.

 

In addition, the Company had previously adopted the 2015 Stock Incentive Plan (the “2015 Plan”). As of March 31, 2026, there were 349,626 stock options outstanding and 15,093 unvested RSAs outstanding under the 2015 Plan. On August 12, 2024, the effective date of the 2024 Plan, there were no remaining shares available for grant under the 2015 Plan.

 

Restricted Stock Awards

 

There were no RSAs granted during the three months ended March 31, 2026. At March 31, 2026, the total estimated unrecognized compensation cost related to unvested service-based RSAs and unvested performance based RSAs was approximately $6,000 and $42,000, respectively. The unrecognized cost related to service-based RSAs is expected to be recognized over the remaining weighted average vesting period of 0.17 years. The unrecognized cost related to performance-based RSAs will be recognized ratably over the performance period based upon the probable number of shares expected to vest. During the three months ended March 31, 2026 and 2025, there was no expense recorded for the outstanding performance-based RSAs.

 

The following summarizes our RSAs transaction activity for three months ended March 31, 2026:

        
   Restricted Common Stock Award Shares   Weighted Average Grant Date Fair Value ($) 
Unvested balance at December 31, 2025   17,617    3.10 
Granted   –    – 
Vested   (2,524)   2.11 
Forfeited   –    – 
Unvested balance at March 31, 2026   15,093    3.27 

 

Restricted Stock Units

 

At March 31, 2026, the total estimated unrecognized compensation cost related to unvested RSUs was approximately $960,000. This cost is expected to be recognized over the remaining weighted average vesting period of 0.37 years.

 

The following summarizes our RSUs transaction activity for the three months ended March 31, 2026:

        
   Restricted Common Stock Unit Shares   Weighted Average Grant Date Fair Value ($) 
Outstanding at December 31, 2025   617,236    9.13 
Granted   –    – 
Vested and settled   (339,555)   9.15 
Forfeited   –    – 
Outstanding at March 31, 2026   277,681    9.12 
Unvested at March 31, 2026   277,681    9.12 

 

During the three months ended March 31, 2026, the Company withheld 121,874 shares of common stock related to the net settlement of certain RSUs that settled during the period to cover the withholding of taxes in the amount of $527,716.

 

Stock Options

 

The following summarizes our stock option transaction activity for the three months ended March 31, 2026:

        
   Number of Stock Options   Grant Date Weighted Average Exercise Price ($) 
Outstanding at December 31, 2025   1,841,977    6.51 
Options granted   –    – 
Options exercised   –    – 
Options canceled and forfeited   –    – 
Outstanding at March 31, 2026   1,841,977    6.51 

 

As of March 31, 2026, total unrecognized stock-based compensation cost related to stock options was approximately $4,882,000. This cost is expected to be recognized over the weighted average remaining period of 1.32 years.

 

The following table summarizes the stock-based compensation expense recorded in the accompanying unaudited condensed consolidated statements of operations during the three months ended March 31, 2026 and 2025:

              
   Three Months Ended March 31, 
   2026   2025 
Research and development  $156,670   $128,926 
General and administrative   1,199,719    996,175 
Total  $1,356,389   $1,125,101 

 

The Company has not recognized and does not expect to recognize in the near future, any tax benefit related to employee stock-based compensation expense as a result of the full valuation allowance related to its net deferred tax assets.